| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/22/1997 | CN1141040A 6-substituted mycophenolic and derivatives with immunosuppressive activity |
| 01/22/1997 | CN1141038A 5-substituted derivatives of mycophenolic acid |
| 01/22/1997 | CN1141033A DP-IV-serine protease inhibitors |
| 01/22/1997 | CN1141011A Particulate material |
| 01/22/1997 | CN1140997A Vanadate compounds for the treatment of proliferative disorders metastases and drug resistant tumors |
| 01/22/1997 | CN1140994A Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| 01/21/1997 | US5595999 Guanidine derivatives |
| 01/21/1997 | US5595995 Anticarcinogenic agents |
| 01/21/1997 | US5595976 Tetrahydropyran compounds |
| 01/21/1997 | US5595972 Polypeptides for signals |
| 01/21/1997 | US5595888 Recombinant methods of making gamma interferon compositions |
| 01/21/1997 | US5595738 Immunology and antigens for tumor |
| 01/21/1997 | CA2033249C Cytostatic or cytotoxic combination of active substances for use in therapeutic procedures |
| 01/21/1997 | CA2022682C Cycloalkylene azoles, processes for their production and use, and pharmaceutical preparations obtained therefrom |
| 01/16/1997 | WO1997001636A2 Recombinant mistletoe lectin |
| 01/16/1997 | WO1997001579A2 Somatostatin peptides |
| 01/16/1997 | WO1997001571A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/16/1997 | WO1997001570A1 Colchicine derivatives, the use thereof and formulations containing them |
| 01/16/1997 | WO1997001569A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 01/16/1997 | WO1997001553A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | WO1997001536A1 4-aryl-1-phenylalkyl-1,2,3,6-tetrahydropyridines having neurotrophic and neuroprotective activity |
| 01/16/1997 | WO1997001360A2 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
| 01/16/1997 | WO1997001353A1 Use of il-11 to treat inflammation |
| 01/16/1997 | WO1997001344A2 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 01/16/1997 | WO1997001336A1 Use of lamellarin-class alkaloids in methods of treatment |
| 01/16/1997 | WO1997001335A1 Di- and trivalent small molecule selectin inhibitors |
| 01/16/1997 | WO1997001275A1 Combinations of inhibitors of farnesyl-protein transferase |
| 01/16/1997 | WO1996027378A3 Use of penciclovir for the treatment of human herpes-virus-8 |
| 01/16/1997 | DE19525784A1 Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD) Autoreactive peptides from human glutamic acid decarboxylase (GAD) |
| 01/16/1997 | DE19525416A1 Verwendung von MP52 zur Behandlung und Prävention von Erkrankungen des Nervensystems Use of MP52 for the treatment and prevention of diseases of the nervous system |
| 01/16/1997 | CA2225682A1 Method of dynamic retardation of cell cycle kinetics to potentiate cell damage |
| 01/16/1997 | CA2225255A1 Combinations of inhibitors of farnesyl-protein transferase |
| 01/16/1997 | CA2224516A1 Piperidine and morpholine derivatives and their use as therapeutic agents |
| 01/16/1997 | CA2224346A1 Diglycosylated 1,2-diols as mimetics of sialyl-lewis x and sialyl-lewis a |
| 01/16/1997 | CA2220554A1 Use of il-11 to treat inflammation |
| 01/15/1997 | EP0753071A1 Cell-targeted lytic pore-forming agents |
| 01/15/1997 | EP0753062A1 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 01/15/1997 | EP0753015A1 Monoclonal antibodies recognizing tie-receptor and their use |
| 01/15/1997 | EP0753012A1 A new 78 residue polypeptide (nk-lysine) and its use |
| 01/15/1997 | EP0753007A1 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same |
| 01/15/1997 | EP0753006A1 Vpr AND Vpx PROTEINS OF HIV |
| 01/15/1997 | EP0753002A1 Modified oligonucleotides and intermediates useful in nucleic acid therapeutics |
| 01/15/1997 | EP0753000A1 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them |
| 01/15/1997 | EP0752986A1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists |
| 01/15/1997 | EP0752985A1 Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
| 01/15/1997 | EP0752886A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/15/1997 | EP0752876A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
| 01/15/1997 | EP0752875A1 Glioblastoma-derived angiogenesis inhibiting factor |
| 01/15/1997 | EP0752874A1 Enhanced virus-mediated dna transfer |
| 01/15/1997 | EP0752873A1 Labelled peptide compounds |
| 01/15/1997 | EP0752872A1 Nadh oxidase as a target in diagnosis and therapy |
| 01/15/1997 | EP0752870A1 Immunotherapeutic agent and its use |
| 01/15/1997 | EP0752857A1 AN IMPROVED METHOD OF SYNTHESIS FOR 6,9-BIS (2-AMINOETHYL)AMINO]BENZO g]ISOQUINOLINE-5,10-DIONE AND ITS DIMALEATE SALT |
| 01/15/1997 | EP0752849A1 Heme-bearing microparticles for targeted delivery of drugs |
| 01/15/1997 | EP0752844A1 Human osteoclast-derived cathepsin |
| 01/15/1997 | EP0663907B1 Method of preparing taxane derivatives |
| 01/15/1997 | EP0642528B1 Phosphotriester-type biologically active compounds |
| 01/15/1997 | EP0519971B1 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS WHICH CAN BE FORMED FROM 1,3,4,6,7,8-HEXAHYDRO-2H-PYRIMIDO-(1,2-a)-PYRIMIDINE |
| 01/15/1997 | EP0514451B1 Dietary supplements comprising vitamins and minerals |
| 01/15/1997 | EP0473708B1 2-halo-9-(2-deoxy-2-fluoro-b-d-arabinofuranosyl) adenine nucleoside derivatives |
| 01/15/1997 | EP0440742B1 Liposome immunoadjuvants containing il-2 |
| 01/15/1997 | CN1140456A Superagonists and antagonists of H IL-6, and 3-D modelling method for their selection |
| 01/15/1997 | CN1140453A 3'-substd. nucleoside derivs. |
| 01/15/1997 | CN1140165A Arylsulfonyl hydroxamic acid derivatives |
| 01/14/1997 | US5594157 Process for making taxol derivatives |
| 01/14/1997 | US5594139 From 5-hal-2,6-diamino-3h-4-oxopyrimidine |
| 01/14/1997 | US5594105 Peptide inhibitors of mitogenesis and motogenesis |
| 01/14/1997 | US5594022 Carbamates |
| 01/14/1997 | US5593992 Cytokine inhibitors |
| 01/14/1997 | US5593990 Methods and compositions for inhibition of angiogenesis |
| 01/14/1997 | US5593987 Methods of inhibiting breast disorders |
| 01/14/1997 | US5593981 Method and treatment of androgen-related diseases |
| 01/14/1997 | US5593976 New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds |
| 01/14/1997 | US5593884 Oncoprotein protein kinase |
| 01/14/1997 | US5593665 Pharmaceutical compositions |
| 01/14/1997 | US5593664 Polyamides, polyureas |
| 01/14/1997 | CA2088671C Use of canps-inhibitors in pharmaceutical preparations |
| 01/09/1997 | WO1997000957A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 01/09/1997 | WO1997000946A1 Immortalized epithelial tumor cell |
| 01/09/1997 | WO1997000882A1 Therapeutic compounds |
| 01/09/1997 | WO1997000880A1 Novel anthracycline derivatives having 4-amino-2,4,6-trideoxy-2-fluoro-mannopyranosyl group |
| 01/09/1997 | WO1997000876A1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 01/09/1997 | WO1997000695A1 Haemopoietic growth factor antagonists and uses therefor |
| 01/09/1997 | WO1997000693A1 Novel formulation for peptide release |
| 01/09/1997 | WO1997000691A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | WO1996039511A3 A c5a-like seven transmembrane receptor |
| 01/09/1997 | WO1996038556A3 Deltap62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer |
| 01/09/1997 | WO1996037214A3 Compositions of interleukin and pyrimidine nucleosides |
| 01/09/1997 | CA2225517A1 Haemopoietic growth factor antagonists and uses therefor |
| 01/09/1997 | CA2225460A1 Transcriptional regulation of genes encoding vascular endothelial growth factor receptors |
| 01/09/1997 | CA2225401A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | CA2225336A1 Novel anthracycline derivatives having 4-amino-2,4,6-trideoxy-2-fluoro-mannopyranosyl group |
| 01/09/1997 | CA2225247A1 Therapeutic compounds |
| 01/09/1997 | CA2224797A1 Immortalized epithelial tumor cell |
| 01/08/1997 | EP0752248A1 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 01/08/1997 | EP0751992A1 Vascular endothelial growth factor 2 |
| 01/08/1997 | EP0751955A1 Super proteins including interferons and interleukins |
| 01/08/1997 | EP0751932A1 Vitamin-d amide derivatives |
| 01/08/1997 | EP0751788A1 Composition including a recombinant plasmid, and uses thereof as a vaccine and drug |
| 01/08/1997 | EP0751781A1 Method of preventing or treating disease characterized by neoplastic cells expressing cd40 |